XML 59 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Additions and Returns of Product Rights - Change in Consideration (Details) - Vaprisol
9 Months Ended
Sep. 30, 2021
USD ($)
Loss Contingency Accrual [Roll Forward]  
Beginning balance $ 8,200,552
Cash payment of royalty during the period (1,792,573)
Change in fair value of contingent consideration included in operating expenses (632,646)
Contingent consideration earned and accrued in operating expenses 1,134,333
Ending balance $ 6,909,666